«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:

2012年第6期

页码:

777-779

栏目:

综述

出版日期:

2012-12-25

文章信息/Info

Title:

Recent research progress in prevention and therapy of vein graft disease

作者:

程永庆¹; 邹榕江²综述; 王东进¹审校

(1.南京大学医学院附属鼓楼医院心胸外科，江苏 南京 210008；2.上海交通大学附属第一人民医院心胸外科，上海 200080)

Author(s):

CHENG Yong-qing¹;  ZOU Rong-jiang²;  WANG Dong-jin¹

(1.Department of Cardiothoracic Surgery, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210008, Jiangsu, China; 2.Department of Cardiothoracic Surgery, Shanghai First People’s Hospital, Jiaotong University, Shanghai 200080, China

关键词:

移植静脉病; 预防; 治疗

Keywords:

vein graft disease;  prevention;  therapy

分类号:

R543.6

DOI:

-

文献标识码:

A

摘要:

自体静脉作为桥血管材料移植到动脉环境后发生的移植静脉病，目前仍是心血管外科尚未解决的难题。现就近年来在移植静脉病的防治方面的研究现状进行综述。

Abstract:

Vein graft disease, caused by autologous vein as vessel grafting when transposed into the arterial circulation, presents an unresolved dilemma in cardiovascular surgical practice. This paper reviews recent progress in the prevention and therapy of vein graft disease.

参考文献/References

[1]Johansson BL,Souza DSR,Bodin L,et al.No touch vein harvesting technique for CABG improves the long-term clinical outcome[J].Scand Cardiovasc J,2009,43(1):63-68.
[2]Chan V,Kulik A,Bourke ME,et al.Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery[J].J Card Surg,2007,22(6):493-497.
[3]Zou RJ,Zou LJ,Huang SD,et al.Effect of external stents on prevention of intimal hyperplasia in a canine vein graft model[J].Chin Med J (Engl),2007,120(24):2264-2267.
[4]Haraguchi T,Okada K,Tabata Y,et al.Controlled release of basic fibroblast growth factor from gelatin hydrogel sheet improves structural and physiological properties of vein graft in rat[J].Arterioscler Thromb Vasc Biol,2007,27(3):548-555.
[5]de Graaf R,Kloppenburg G,Tintu A,et al.The new immunosuppressive agent FK778 attenuates neointima formation in an experimental venous bypass graft model[J].Vascul Pharmacol,2009,50(3-4):83-88.
[6]Cayci C,Wahlquist TC,Seckin SI,et al.Naringenin inhibits neointimal hyperplasia following arterial reconstruction with interpositional vein graft[J].Ann Plast Surg,2010,64(1):105-113.
[7]Schwalm JD,Ahmad M,Velianou JL,et al.Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience[J].Can J Cardiol,2010, 26(2):e40-e44.
[8]Simsek C,Onuma Y,Magro M,et al.Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease[J].Catheter Cardiovasc Interv,2010,76(1):41-49.
[9]Simsek C,Magro M,Boersma E,et al.The unrestricted use of sirolimus-and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries[J].JACC Cardiovasc Interv,2010,3(10):1051-1058.
[10]Vink MA,Dirksen MT,Suttorp MJ,et al.5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction:a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial[J].JACC Cardiovasc Interv,2011,4(1):24-29.
[11]Fujita H,Banno H,Yamanouchi D,et al.Pitavastatin Inhibits Intimal Hyperplasia in Rabbit Vein Graft[J].J Surg Res,2008,148(2):238-243.
[12]Rodés-Cabau J,Bertrand OF,Larose E,et al.Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial[J].Circulation,2009,120(20):1978-1986.
[13]Brilakis ES,Lichtenwalter C,Abdel-Karim AR,et al.Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial[J].JACC Cardiovasc Interv,2011,4(2):176-182.
[14]Wijns W,Kolh P,Danchin N,et al.Guidelines on myocardial revascularization[J].Eur Heart J,2010,31(20):2501-2555.

备注/Memo

备注/Memo:

收稿日期：2012-05-02.通讯作者：王东进，主任医师， 主要从事冠心病及胸部大血管外科研究 Email:gldjw@163.com 作者简介：程永庆，主治医师，硕士 Email:cyq197549@sina.com

常用功能

更新日期/Last Update: 2012-12-30